NCT04193163View on ClinicalTrials.gov

Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device

RecruitingOBSERVATIONAL
Enrollment

268

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions
Hip DiseaseHip Fractures
Interventions
DEVICE

Hip prosthesis - ESOP 2 cementless femoral stem

ESOP 2 femoral stems are intended to be implanted in the femoral region during total hip arthroplasty in order to restore joint function.

Trial Locations (7)

33000

RECRUITING

Clinique Tivoli Ducos, Bordeaux

RECRUITING

Nouvelle Clinique Bel-Air, Bordeaux

67504

NOT_YET_RECRUITING

CH de Haguenau, Haguenau

68024

RECRUITING

CH Pasteur, Colmar

69130

NOT_YET_RECRUITING

Clinique du Val d'Ouest, Écully

75651

RECRUITING

Groupe Hospitalier Pitié-Salpêtrière, Paris

92380

NOT_YET_RECRUITING

CH Raymond POINCARE, Garches

All Listed Sponsors
lead

FH ORTHO

INDUSTRY